Showing results (2121-2130 of 2,519) with videos related to

Sort By:
Pageof 252
Singapore Medical Journal|May 30, 2013
Ministry of health clinical practice guidelines: dementiaK Nagaendran, L H Christopher Chen, M S Chong, et al.
JAMA|January 5, 2012
Bariatric surgery and long-term cardiovascular eventsLars Sjöström, Markku Peltonen, Peter Jacobson, et al.
Plos Biology|December 22, 2021
The human gut symbiont Ruminococcus gnavus shows specificity to blood group A antigen during mucin glycan foraging: Implication for niche colonisation in the gastrointestinal tractHaiyang Wu, Emmanuelle H Crost, C David Owen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2018
IDO1 Inhibition Synergizes with Radiation and PD-1 Blockade to Durably Increase Survival Against Advanced GlioblastomaErik Ladomersky, Lijie Zhai, Alicia Lenzen, et al.
Nature|November 3, 2006
Global distribution and conservation of rare and threatened vertebratesRichard Grenyer, C David L Orme, Sarah F Jackson, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 18, 2020
Patient-reported outcomes, physician-reported toxicities, and treatment outcomes in a modern cohort of patients with sinonasal cancer treated using proton beam therapyDario Pasalic, Ethan B Ludmir, Pamela K Allen, et al.
Nature Communications|June 17, 2024
Cancer-associated Histone H3 N-terminal arginine mutations disrupt PRC2 activity and impair differentiationBenjamin A Nacev, Yakshi Dabas, Matthew R Paul, et al.
Med (New York, N.Y.)|March 29, 2024
Icosapent ethyl modulates circulating vascular regenerative cell content: The IPE-PREVENTION CardioLink-14 trialEhab Bakbak, Aishwarya Krishnaraj, Deepak L Bhatt, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2011
Priming of hypoxia-inducible factor by neuronal nitric oxide synthase is essential for adaptive responses to severe anemiaAlbert K Y Tsui, Philip A Marsden, C David Mazer, et al.
Current Topics in Medicinal Chemistry|October 8, 2009
Discovery and development of a potent and highly selective small molecule muscarinic acetylcholine receptor subtype I (mAChR 1 or M1) antagonist in vitro and in vivo probeC David Weaver, Douglas J Sheffler, L Michelle Lewis, et al.
Pageof 252